Icad Inc Quick Ratio (ICAD) starting from the first quarter 2025 to first quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Icad Inc  (NASDAQ: ICAD)

Icad Inc's Quick Ratio

ICAD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Icad Inc's Cash & cash equivalent grew by 16.42 % in the Q1 2025 sequentially, faster than Current Liabilities, this led to improvement in Icad Inc's Quick Ratio to 2.69, above Icad Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Quick Ratio than Icad Inc in first quarter 2025. While Quick Ratio total ranking has improved so far during the Q1 2025 to 701, from total ranking in the fourth quarter 2024 at 1029.

Explain Quick Ratio?
How much Cash & cash equivalents ICAD´s has?
What are ICAD´s Current Liabilities?




ICAD Quick Ratio (Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
Y / Y Current Liabilities Change 25.47 % 11.77 % -45.04 % -46.69 % -53.85 %
Y / Y Cash & cash equivalent Change -1.24 % -20.6 % -1.33 % 6.91 % 3.16 %
Quick Ratio MRQ 2.69 2.35 3 3.21 3.41
ICAD's Total Ranking # 701 # 1029 # 706 # 480 # 743
Seq. Current Liabilities Change 1.72 % 16.9 % -1.06 % 6.65 % -9.39 %
Seq. Cash & cash equivalent Change 16.42 % -8.44 % -7.66 % 0.34 % -6.4 %



Quick Ratio first quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 39
Healthcare Sector # 346
Overall Market # 701


Quick Ratio Statistics
High Average Low
3.53 1.54 0.53
(Mar 31 2021)   (Dec 31 2013)




Financial Statements
Icad Inc's Current Liabilities $ 7 Millions Visit ICAD's Balance sheet
Icad Inc's Cash & cash equivalent $ 20 Millions Visit ICAD's Balance sheet
Source of ICAD's Sales Visit ICAD's Sales by Geography


Cumulative Icad Inc's Quick Ratio

ICAD's Quick Ratio for the trailling 12 Months

ICAD Quick Ratio

(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -23.48 % -39.44 % -44.09 % -37.11 % -28.99 %
Y / Y Cash & cash equivalent TTM Growth -4.56 % -3.5 % 2.58 % -3.84 % -13.7 %
Quick Ratio TTM 2.79 2.96 3.23 2.69 2.24
Total Ranking TTM # 3267 # 3380 # 2442 # 3234 # 2282
Seq. Current Liabilities TTM Growth 5.85 % 3.07 % -16.99 % -15.51 % -16.23 %
Seq. Cash & cash equivalent TTM Growth -0.33 % -5.5 % -0.31 % 1.64 % 0.78 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q1 2025 to $7.46 millions, cumulative Quick Ratio decreased to 2.79 above the ICAD average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 194 other companies have achieved higher Quick Ratio than Icad Inc. While Quick Ratio overall ranking has improved so far to 3267, from total ranking during the twelve months ending fourth quarter 2024 at 3380.

Explain Quick Ratio?
How much Cash & cash equivalents ICAD´s has?
What are ICAD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 195
Healthcare Sector # 901
Within the Market # 3267


trailing twelve months Quick Ratio Statistics
High Average Low
3.12 1.51 0.69
(Sep 30 2024)   (Sep 30 2018)




Companies with similar Quick Ratio in the quarter ending Mar 31 2025, within Medical Equipment & Supplies Industry Quick RatioMar 31 2025 MRQ Cash & cash equivalentMar 31 2025 MRQ Current Liabilities
Modular Medical Inc  6.73 $ 13.095  Millions$ 1.946  Millions
Monogram technologies inc   6.71 $ 13.270  Millions$ 1.978  Millions
Kestra Medical Technologies Ltd   6.29 $ 237.595  Millions$ 37.790  Millions
Procept Biorobotics Corporation  6.07 $ 316.207  Millions$ 52.064  Millions
Retractable Technologies Inc  5.96 $ 35.706  Millions$ 5.987  Millions
Iradimed Corporation  5.94 $ 50.331  Millions$ 8.473  Millions
Alpha Pro Tech Ltd   5.79 $ 13.352  Millions$ 2.306  Millions
Vicarious Surgical Inc  5.67 $ 37.362  Millions$ 6.592  Millions
Irhythm Holdings Inc   5.66 $ 520.589  Millions$ 91.922  Millions
Transmedics Group Inc   5.58 $ 310.143  Millions$ 55.603  Millions
Outset Medical Inc   5.52 $ 189.002  Millions$ 34.223  Millions
Autonomix Medical Inc   5.35 $ 9.136  Millions$ 1.707  Millions
Tactile Systems Technology Inc   4.91 $ 83.619  Millions$ 17.033  Millions
Tenon Medical Inc   4.70 $ 10.311  Millions$ 2.195  Millions
Glucotrack Inc   4.67 $ 9.100  Millions$ 1.950  Millions
Neuropace Inc   4.51 $ 66.262  Millions$ 14.707  Millions
Glaukos Corp  4.36 $ 298.696  Millions$ 68.529  Millions
Anika Therapeutics Inc   4.21 $ 75.358  Millions$ 17.901  Millions
Hyperfine Inc   4.15 $ 33.093  Millions$ 7.979  Millions
Co diagnostics Inc   3.99 $ 21.479  Millions$ 5.377  Millions
Alphatec Holdings Inc   3.71 $ 153.244  Millions$ 41.320  Millions
Nexalin Technology Inc   3.57 $ 2.051  Millions$ 0.575  Millions
Inspiremd Inc   3.54 $ 26.086  Millions$ 7.367  Millions
Anteris Technologies Global Corp   3.52 $ 48.955  Millions$ 13.916  Millions
Strata Critical Medical Inc   3.40 $ 35.693  Millions$ 10.505  Millions
Orchestra Biomed Holdings Inc   3.35 $ 49.884  Millions$ 14.899  Millions
Apyx Medical Corp  3.26 $ 31.011  Millions$ 9.510  Millions
Staar Surgical Co  3.26 $ 222.761  Millions$ 68.356  Millions
Longduoduo Co Ltd  3.26 $ 0.947  Millions$ 0.291  Millions
Nutriband Inc   3.20 $ 2.964  Millions$ 0.925  Millions

Date modified: 2026-09-12T06:14:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.